Medexus Pharma, Inc.

IL · United States · Reporting entity ID 100000061326

Total reported 2019–2025

$491K

#1,577 of 2,960 reporting companies — 0% of all reported industry payments

$340K in general payments across 3,217 records, plus $151K in research funding across 3 records.

How it breaks down

General payments $340,140

Research funding $150,552

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.